The nasal route has the advantage of self-medication by patients due to the easy accessibility of the nasal cavity (Khafagy et al., 2009a)
1.5 mg once daily for the first month Increased to 4 mg once daily for the second month Then 9 mg once daily for the third month Up to the 25 mg once daily maintenance dose, reached gradually if tolerated It is incredibly important that dose increases are never rushed
Its main concerns involve cardiovascular effects, insomnia, and potential for dependence
Treatment begins with 2.5mg weekly for four weeks, serving as an initiation dose to assess tolerance
e , Relative abundance of SLC25A39, GCLM and SLC25A40 transcripts in HEK-293T cells treated with BSO (1 mM) for the indicated days using quantitative reverse transcription PCR (RT-qPCR), normalized to transcripts of -ACTIN
Some of the alleged injuries include gastrointestinal conditions, pancreatic diseases, gallbladder issues, and blood clots